Recent advances in machine learning technology may help doctors to decide on better treatments related to Acute severe ulcerative colitis (ASUC). Ulcerative colitis (UC) is a disease condition that is ...

Takeda ( TSE:4502/NYSE:TAK) announced new data from VERDICT ( NCT04259138), showing that treating adults with intravenous ENTYVIO ® (vedolizumab) to achieve corticosteroid-free (CSF) disease clearance ...

What Does Treatment Failure Mean if You Have Ulcerative Colitis? Alan Moss, MD, chief scientific officer of the Crohns & Colitis Foundation, defines what constitutes ulcerative colitis treatment ...

The American Gastroenterological Association (AGA) has released a new clinical guideline on the pharmacological management of moderate-to-severe ulcerative colitis, published in Gastroenterology. This ...

AGA living guideline recommends patients start advanced therapies early in their disease course rather than gradual step-up treatment approach. “Since the first biologic treatment for ulcerative ...

Shanghai, Aug. 15, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and ...

Credit: Getty Images. Medications for ulcerative colitis include first-line therapy 5-ASA for mild cases as well as immune system–altering biologics for more severe cases. The initial treatment with ...

The American Gastroenterological Association has updated guidance for the treatment of ulcerative colitis to recommend using higher efficacy drugs in earlier stages of treatment, Medscape Medical News ...

Building on Omvoh's approved use and durable efficacy in adults, Lilly plans to submit these data to global regulators to support a potential ...

How Does Tremfya Work for Ulcerative Colitis? Tremfya is a monoclonal antibody that reduces inflammation. The main ingredient in Tremfya is a medicine called guselkumab. This medicine blocks a ...